Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Eribulin mesylate

Cat. No.: IBDI-432423

Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin mesylate inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.

Size (Solid):

Product Details

Target Microtubule/Tubulin | Apoptosis
Molecular Weight 826.00
Appearance Solid
Synonyms B1939 mesylate, E7389 mesylate, ER-086526 mesylate
Purity 99.71%

Storage & Handling

Shipping Shipping with dry ice.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.